These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17329937)

  • 1. Study on variations in price of prescription medicines in Thailand.
    Burapadaja S; Kawasaki N; Kittipongpatana O; Ogata F
    Yakugaku Zasshi; 2007 Mar; 127(3):515-26. PubMed ID: 17329937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Price comparison of high-cost originator medicines in European countries.
    Vogler S; Zimmermann N; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):221-230. PubMed ID: 27658050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
    Gross DJ; Schondelmeyer SW; Raetzman SO
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prices & availability of common medicines at six sites in India using a standard methodology.
    Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
    Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation of prescription drug prices in community pharmacies: A national cross-sectional study.
    Larkin J; Moriarty F; McGuinness S; Finucane K; Fitzgerald K; Smith SM; O'Mahony JF
    Res Social Adm Pharm; 2022 Oct; 18(10):3736-3743. PubMed ID: 35618647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America.
    Wirtz VJ; Santa-Ana-Tellez Y; Trout CH; Kaplan WA
    Health Policy Plan; 2012 Dec; 27(8):638-48. PubMed ID: 22367770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Cardiovascular Medicines Prices in Four European Countries.
    Mitkova Z; Vasileva M; Savova A; Manova M; Terezova S; Petrova G
    Front Public Health; 2020; 8():433. PubMed ID: 32974262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of branded prescription medicine prices in OECD countries.
    Kanavos PG; Vandoros S
    Health Econ Policy Law; 2011 Jul; 6(3):337-67. PubMed ID: 21676345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International comparison of generic medicine prices.
    Simoens S
    Curr Med Res Opin; 2007 Nov; 23(11):2647-54. PubMed ID: 17877848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The price may not be right: the value of comparison shopping for prescription drugs.
    Arora S; Sood N; Terp S; Joyce G
    Am J Manag Care; 2017 Jul; 23(7):410-415. PubMed ID: 28817779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology.
    Sharma A; Rorden L; Ewen M; Laing R
    J Pharm Policy Pract; 2016; 9():12. PubMed ID: 27054040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State prescription drug price Web sites: how useful to consumers?
    Tu HT; Corey CG
    Res Brief; 2008 Feb; (1):1-16. PubMed ID: 18494180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China.
    Wang J; Liu X; Wang S; Chen H; Wang X; Zhou W; Wang L; Zhu Y; Zheng X; Hao M
    Indian J Pharmacol; 2015; 47(5):535-9. PubMed ID: 26600644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equitable Prices of Single-Source Drugs in Thailand.
    Ngorsuraches S; Chaiyakan K
    Appl Health Econ Health Policy; 2015 Aug; 13(4):389-97. PubMed ID: 25894738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries.
    Leopold C; Mantel-Teeuwisse AK; Vogler S; de Joncheere K; Laing RO; Leufkens HG
    Health Policy; 2013 Oct; 112(3):209-16. PubMed ID: 24060335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
    Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
    PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Price discrimination in essential medicines: evidence from International Drug Price Indicator Guide data.
    Hanlon M; Zhang R
    Int Health; 2013 Mar; 5(1):58-63. PubMed ID: 24029847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic competition in Canada.
    Steele JW
    Pharmacoeconomics; 1994 Nov; 6(5):480-2. PubMed ID: 10155276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.